Kyoto, Japan

Rei Kuwabara

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rei Kuwabara: Innovating Immunotherapy from Kyoto

Introduction

Rei Kuwabara is a distinguished inventor based in Kyoto, Japan, known for her groundbreaking work in the field of immunotherapy. Her innovative approach has led to significant advancements in medical science, particularly in forming immune-tolerant sites within body tissues.

Latest Patents

Rei Kuwabara holds a patent titled "Method for forming an immune-tolerant site and method for attracting immunosuppressive cells". This invention provides a novel method that involves contacting an agent, comprising SEK-1005 and/or fibroblast growth factor (FGF), with affected sites in body tissues. The techniques outlined in her patent aim to enhance the body's ability to tolerate transplants and effectively manage autoimmune diseases.

Career Highlights

Throughout her career, Kuwabara has been affiliated with prominent institutions, including Kyoto University, where she has contributed to various research projects that focus on immunology and cell therapy. Her role at Arkray, Inc. has further solidified her standing as a thought leader in her field, as she collaborates on various projects aimed at improving healthcare solutions.

Collaborations

Rei has worked alongside notable colleagues, including Hiroo Iwata and Masahide Hamaguchi. Their collaboration on research initiatives has led to groundbreaking findings in immunotherapy, showcasing the power of teamwork in the scientific community.

Conclusion

With her patent and ongoing research efforts, Rei Kuwabara is poised to make a lasting impact on the medical field, particularly in treatments that require immune modulation. Her work not only reflects her dedication to innovation but also her commitment to enhancing the quality of life through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…